BioNxt Solutions Inc.
BNXTF
$0.26
$0.015.90%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 73.59% | -98.25% | -32.26% | -23.90% | 31.69% |
| Total Depreciation and Amortization | -37.50% | -75.00% | -20.00% | -18.37% | 219.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.21% | 258.19% | 146.51% | 12.66% | -69.05% |
| Change in Net Operating Assets | -206.56% | 170.60% | 111.69% | -515.63% | 142.81% |
| Cash from Operations | -40.38% | 46.18% | 46.58% | -168.53% | 40.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -73.18% | 1,777.78% | -92.35% | 2,615.38% | -97.76% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Investing | -73.18% | 1,777.78% | 370.00% | -176.92% | -97.76% |
| Total Debt Issued | -- | -- | -100.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 349.43% | -29.96% | -50.03% | 214.37% | 219.63% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | 100.00% |
| Cash from Financing | 315.35% | -29.80% | -73.12% | 480.06% | -70.71% |
| Foreign Exchange rate Adjustments | 400.00% | -133.33% | 0.00% | -- | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,794.86% | 89.51% | -187.93% | 243.65% | -213.54% |